SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-060093
Filing Date
2024-07-09
Accepted
2024-07-09 15:37:22
Documents
16
Period of Report
2024-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209161-8k_60degrees.htm   iXBRL 8-K 34662
2 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JULY 9, 2024 ea020916101ex99-1_60degrees.htm EX-99.1 20947
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3002
  Complete submission text file 0001213900-24-060093.txt   287042

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sxtp-20240709.xsd EX-101.SCH 3797
5 XBRL DEFINITION FILE sxtp-20240709_def.xml EX-101.DEF 26644
6 XBRL LABEL FILE sxtp-20240709_lab.xml EX-101.LAB 36712
7 XBRL PRESENTATION FILE sxtp-20240709_pre.xml EX-101.PRE 25268
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0209161-8k_60degrees_htm.xml XML 5744
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241107401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)